Latest debt-to-equity ratio
Entrada Therapeutics Debt-to-equity ratio
Direct answer
Entrada Therapeutics's debt-to-equity ratio is 20.8%.
The verified market snapshot reports 20.8%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 25, 2026.
Get free Entrada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 20.8%
Explore related company data
View Entrada Therapeutics's market capitalizationView Entrada Therapeutics's price-to-book ratioView Entrada Therapeutics's return on equityView Entrada Therapeutics's 52-week price rangeView Entrada Therapeutics's revenue growthView Entrada Therapeutics's profit marginView all Entrada Therapeutics key metricsReturn to Entrada Therapeutics profile